These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10456472)

  • 21. Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs.
    Martin PG; Sukhu K; Chambers E; Giangrande PL
    Clin Lab Haematol; 1999 Apr; 21(2):125-8. PubMed ID: 10342072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disappearance of FVIII inhibitors in a severe hemophilia A neonate after steroid treatment correlated with a cytokine shift toward a T-helper 2 pattern.
    Vianello F; Zanon E; Zerbinati P; Innella B; Girolami A
    Haematologica; 2000 Oct; 85(10):1114-5. PubMed ID: 11025617
    [No Abstract]   [Full Text] [Related]  

  • 23. Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
    Laurian Y; Girma JP; Allain JP; Verroust F; Larrieu MJ
    Scand J Haematol; 1982 Mar; 28(3):233-7. PubMed ID: 6806896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of corticoids in inhibitor suppression in hemophilia A, in addition to continuing treatment with factor VIII concentrate].
    Aznar JA; Jorquera JI; Marty ML
    Sangre (Barc); 1983; 28(3):265-79. PubMed ID: 6414098
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII.
    Verroust F; Allain JP
    Thromb Haemost; 1982 Oct; 48(2):238. PubMed ID: 6817447
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibitor hemophilia in oral surgery].
    Schulz S
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL
    Prog Clin Biol Res; 1981; 72():123-38. PubMed ID: 6801682
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response.
    Penner JA
    Haemophilia; 2001 Jan; 7(1):103-8. PubMed ID: 11136390
    [No Abstract]   [Full Text] [Related]  

  • 31. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Baglin T; Beacham E
    Thromb Haemost; 1998 Dec; 80(6):1036-7. PubMed ID: 9869186
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.
    Klinge J; Auerswald G; Budde U; Klose H; Kreuz W; Lenk H; Scandella D;
    Haemophilia; 2001 Jan; 7(1):26-32. PubMed ID: 11136377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered immunology in haemophilia.
    Jones P; Proctor S; Dickinson A; George S
    Lancet; 1983 Jan; 1(8316):120-1. PubMed ID: 6129429
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.
    Cid AR; Casaña P; Cabrera N; Haya S; Cortina V; Aznar JA
    Haemophilia; 2007 Mar; 13(2):206-8. PubMed ID: 17286776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilia--darkest hours before the dawn.
    Street AM; Ekert H
    Med J Aust; 1996 Apr; 164(8):453-5. PubMed ID: 8614331
    [No Abstract]   [Full Text] [Related]  

  • 36. [Factor VIII inhibitors].
    Ruggeri ZM; Bader R; Coppola R; Mannuccio Mannucci P
    Ric Clin Lab; 1977; 7 Suppl 2():17-29. PubMed ID: 339315
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study.
    Jardim LL; van der Bom J; Brommonschenkel CC; Gouw SC; Rezende SM;
    Br J Haematol; 2019 Jul; 186(1):152-155. PubMed ID: 30556277
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of a lacerated frenum and lip in a child with severe hemophilia and an inhibitor: report of case.
    Powell D
    ASDC J Dent Child; 1976; 43(4):272-5. PubMed ID: 783228
    [No Abstract]   [Full Text] [Related]  

  • 39. The response to factor VIII infusion in inhibitor patients.
    Allain JP; Verroust F
    Prog Clin Biol Res; 1984; 150():99-108. PubMed ID: 6431445
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of factor VIII after inhibitor clearance in patients with moderate haemophilia A: a case series.
    Tran DQ; Harvey RD; Meeks SL; Chapman R; Kempton CL
    Haemophilia; 2014 Jul; 20(4):e344-6. PubMed ID: 24750497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.